How Long Does Semaglutide Take to Work?

Summary: Appetite quiets in the first one to two weeks, the scale starts moving by week four to eight, and the larger weight loss arrives after you titrate up around month three to four.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: semaglutide starts quieting your appetite within 1 to 2 weeks of your first injection, the scale typically moves by week 4 to 8 (around 2 to 4 pounds at the 0.25 mg starting dose), and the bigger weight loss shows up after you titrate to higher doses around month 3 to 4. The STEP 1 trial that supported Wegovy's approval reported roughly 5% body weight loss by week 12, 10% by week 28, and 15% by week 68 [1]. Blood sugar moves faster than weight does. If you have type 2 diabetes, fasting glucose drops within the first week or two on Ozempic, and HbA1c follows over about three months [3].

Below is the week-by-week timeline, what slows the response down, what speeds it up, what to do when the scale plateaus, and how to read the difference between the diabetes timeline and the obesity timeline.

The week-by-week timeline

WeeksDose (Wegovy titration)What you feelTypical scale change
1 to 40.25 mgLess hunger, smaller portions feel full0 to 4 lb
5 to 80.5 mgStronger appetite suppression, "food noise" fading3 to 7 lb cumulative
9 to 121.0 mgCravings reduced, energy stabilizing~5% body weight (STEP 1)
13 to 201.7 mgBigger weekly losses, clothes fitting differently7 to 10% cumulative
20 to 282.4 mg maintenanceSteady losses, plateau periods normal~10% (STEP 1 week 28)
28 to 682.4 mg maintenanceSlower but continued loss~15% (STEP 1 week 68)

That table is the average. Half of patients lose faster than this, half lose slower, and a small fraction barely respond at all. The trajectory is what matters, not the week-to-week wiggle.

What's happening in the first week

You inject 0.25 mg subcutaneously on day one. Within hours, semaglutide is binding GLP-1 receptors in your gut, your pancreas, and the appetite centers in your hypothalamus. The half-life of semaglutide is about 7 days, which is why it is dosed once weekly and why steady-state plasma concentrations take 4 to 5 weeks to build [3].

By day three or four most people notice something has shifted. Meals end sooner. The drive to snack at night fades. Some describe it as "the food chatter went quiet." A few report nothing in week one, then a sudden shift in week two when blood levels climb closer to steady state. Both patterns are normal.

What is not normal in week one: dramatic weight loss. The 0.25 mg dose is a tolerance step, not a therapeutic dose. If you drop 8 pounds in the first week, most of that is water and reduced food volume in your gut, not fat. The actual fat-loss curve does not really begin until the dose climbs.

Weeks 2 to 4: the appetite shift gets serious

By week two the appetite suppression is usually unmistakable. Portion sizes that used to feel normal now feel oppressive. Coffee and water seem to fill you up. Some people lose 2 to 4 pounds in this window without consciously dieting.

Side effects also peak here. Nausea, constipation, and an occasional sour taste in the mouth are the headliners. They almost always reflect slowed gastric emptying, which is the same mechanism producing the weight loss. Manage them with smaller meals, more water, and bland food. They typically fade by week three or four as the gut adapts.

You stay at 0.25 mg for the full first month regardless. The label does not allow earlier escalation, and clinical experience confirms that people who try to jump ahead get punished with GI side effects severe enough to make them quit.

Weeks 4 to 12: the dose climbs and the scale moves

Week 5 brings the first titration step to 0.5 mg. Four weeks later, 1.0 mg. By week 13 you are at 1.7 mg if you are following the standard Wegovy schedule [2]. This is where the curve gets steep.

STEP 1 reported a mean body weight reduction of about 5% by week 12. For a 220-pound starting weight that is roughly 11 pounds. Some patients double that. A minority show essentially no change in the first 12 weeks but then respond once they reach 2.4 mg. The trial protocol allowed up to 16 weeks of titration before assessing response, which is a more honest deadline than the 4-week one people put on themselves.

Weeks 12 to 28: maintenance dose, the bigger drops

By week 17 or thereabouts you reach the 2.4 mg maintenance dose. This is the dose STEP 1 used for the bulk of the trial. Week 28 was a key checkpoint in that trial and the mean weight loss was approximately 10% [1]. People who reach this point and stick with it usually find the next 40 weeks deliver the second half of their total weight loss.

For type 2 diabetes the picture at this stage is different. HbA1c reductions of 1.5 to 1.8 percentage points are typical at the 1.0 mg and 2.0 mg doses of Ozempic [3][4]. Fasting glucose drops faster than HbA1c because HbA1c reflects a 90-day average. Patients who started with an HbA1c of 8.5 often see it sitting around 6.8 to 7.0 by month three, and weight loss in this group runs 5 to 10 pounds in the same window, which is real but smaller than the obesity dose produces.

Weeks 28 to 68: the long tail

STEP 1's headline number was 14.9% mean body weight loss at week 68 [1]. That trajectory is not linear. Most people lose the steepest stretch between months 3 and 9, then the rate slows. Plateaus of 3 to 6 weeks are normal in this window and do not signal that the drug has stopped working. They signal that your body has adapted to the current calorie deficit and your metabolic rate has adjusted downward, which is expected behavior in any weight loss program, not a failure of semaglutide.

People who continue to dose past 68 weeks generally hold their loss. The STEP 4 trial showed that patients who stopped semaglutide at week 20 regained two-thirds of their lost weight within a year, while patients who continued kept losing slowly or held steady. Weight loss is the drug's effect. Maintaining the loss requires maintaining the drug, or replacing it with another sustained intervention.

What slows the response

Several variables stretch the timeline.

Titration interruptions. If side effects force you to pause at 0.5 mg for an extra month before stepping up to 1.0 mg, your full effective dose arrives a month later. This is the single most common reason real-world patients lag behind trial timelines.

Suboptimal injection technique. Semaglutide is subcutaneous, not intramuscular. Pushing too deep, hitting muscle, injecting into scarred tissue, or rushing the plunger can leak the dose. Hold for 5 seconds after the plunger is fully down before withdrawing.

Storage problems. Wegovy and Ozempic pens stored above the labeled temperature range can lose potency. The Wegovy label specifies refrigerated storage at 36 to 46 degrees Fahrenheit, with limited room-temperature stability after first use [2]. A pen left in a hot car for a weekend may not work.

Concurrent medications that blunt the response. Insulin and sulfonylureas combined with semaglutide can produce hypoglycemia but do not affect weight loss timing. Stimulants and antipsychotics can dampen the appetite signal. SSRIs and tricyclics are generally neutral on the semaglutide weight loss curve.

Eating patterns that override the satiety signal. Liquid calories, especially sweetened drinks and alcohol, bypass most of the gastric-emptying mechanism that produces semaglutide's fullness signal. People who drink 800 daily calories of sweetened coffee, juice, or beer often barely lose weight on therapeutic doses because the drug cannot suppress what it never registers.

Genuine non-response. A small fraction of patients, roughly 10 to 15% in trial data, lose less than 5% of body weight even at maintenance dose for 16 weeks. The mechanism is not fully understood, but the FDA label suggests reassessment after 16 weeks at 2.4 mg [2]. Switching to tirzepatide is the most common next step.

What speeds the response

Sticking to the titration schedule. The patients who hit 2.4 mg on week 17 see the biggest losses at week 28. There is no shortcut, but staying on the ladder matters.

Eating protein first. Protein triggers GLP-1 and CCK release independently of semaglutide. A meal that starts with protein produces a stronger satiety response than the same calories starting with carbohydrate. The drug's effect stacks on top.

Resistance training. Strength training during weight loss preserves lean mass, keeps metabolic rate higher, and lets the calorie deficit produced by semaglutide come from fat rather than muscle. STEP 1 did not require resistance training, but the trials that combined it with semaglutide showed better body composition outcomes.

Sleep. Six hours or less of sleep raises ghrelin, which is the hunger hormone semaglutide is competing against. Getting back to seven or eight hours nightly amplifies the drug's appetite effect.

Hydration. Semaglutide slows gastric emptying. Inadequate water intake compounds that into constipation and a general sense of digestive sluggishness, which gets misread as "the drug isn't working." Most people need an extra 16 to 24 ounces a day on semaglutide.

Plateaus and what to do about them

A plateau of 2 to 6 weeks at any point during semaglutide therapy is normal. The body adjusts metabolic rate downward as you lose mass, and the calorie deficit shrinks. Three things break a plateau without changing drugs.

  1. Audit calorie intake. Plateaus often coincide with calorie creep that did not exist when the drug started. People eating 1500 calories at month 2 are often eating 2000 by month 5 without noticing.
  2. Add or increase resistance training. More lean mass means a higher metabolic floor.
  3. Wait. Most plateaus break on their own within 6 weeks if calories and activity hold steady.

If the plateau extends past 8 weeks at maintenance dose, talk to your prescriber. Options include staying the course, briefly cycling off, or switching to tirzepatide, which acts on both GIP and GLP-1 receptors and produces larger mean weight loss in head-to-head comparisons.

Diabetes versus obesity: two different timelines

If you are taking semaglutide for type 2 diabetes, the first metric that moves is blood sugar, not weight. Fasting glucose typically drops within 7 to 14 days at the 0.25 mg starting dose [3]. HbA1c reflects 90 days of average glucose, so the full HbA1c effect takes a full quarter to register. Weight loss runs in parallel but slower than the obesity timeline because Ozempic tops out at 2.0 mg.

If you are taking semaglutide for weight loss (Wegovy), blood sugar improvements still happen, but the headline metric is body weight, and the timeline above applies. People without diabetes generally do not need to monitor glucose during therapy.

If you are taking oral semaglutide (Rybelsus) for diabetes, the timeline shifts again. Oral dosing produces lower plasma concentrations than injection, and the FDA-labeled maintenance doses (7 mg, 14 mg daily) target glycemic control rather than maximal weight loss. Expect HbA1c to improve over 12 weeks similarly to the injection, but weight loss is roughly half what the injection produces.

When to call your prescriber

Some timelines warrant a call rather than another week of patience.

  • No appetite change at all by week 4. The dose, the storage, or the injection technique may be off. Pen problems and missed doses are the most common explanations.
  • Severe persistent nausea or vomiting past week 6. Most GI side effects fade by week 4. Persistent vomiting that prevents food or fluid intake is a reason to pause and reassess.
  • Sudden weight gain or fluid retention. Semaglutide does not typically cause this. If it happens, something else is going on.
  • Vision changes in people with diabetic retinopathy. Rapid improvements in blood sugar can transiently worsen retinopathy, a documented risk on the Ozempic label [3].
  • Severe abdominal pain. Pancreatitis is a rare but serious risk on every GLP-1. Persistent upper abdominal pain that radiates to the back warrants immediate evaluation.

Common questions about the semaglutide timeline

How long does semaglutide take to suppress appetite?
Most people notice reduced hunger within 1 to 2 weeks of the first 0.25 mg dose, with stronger appetite suppression by week 4 as plasma levels approach steady state.
Does Wegovy work immediately?
No. The 0.25 mg starting dose produces only mild effects in the first week. Steady-state semaglutide levels take 4 to 5 weeks to build, and the full therapeutic effect arrives after titration to 2.4 mg around week 17.
How fast does semaglutide kick in for weight loss?
Visible scale movement typically starts between weeks 4 and 8, usually 2 to 4 pounds at the 0.25 mg starting dose. The bigger weekly losses begin after titration to higher doses by month 3 to 4.
What should I expect during the first week on semaglutide?
Reduced appetite within 3 to 7 days, possible mild nausea or constipation, and minimal weight change. Some people feel nothing in week one and a clear appetite shift in week two.
How much weight will I lose in the first month?
Average is 2 to 5 pounds at the 0.25 mg starting dose. Faster losses in week one are usually water rather than fat. Real fat loss accelerates after the dose climbs.
When does Wegovy start working for weight loss?
Appetite effects begin in week 1 or 2. Scale movement typically begins by week 4 to 8. Mean weight loss in STEP 1 was about 5% at week 12, 10% at week 28, and 15% at week 68.
Does Wegovy work for everyone?
No. About 85 to 90% of people lose at least 5% of body weight by week 16 at the 2.4 mg maintenance dose. The remaining 10 to 15% are considered non-responders and may benefit from switching to tirzepatide.
How quickly does semaglutide lower blood sugar?
Fasting glucose drops within the first week or two on Ozempic. The full HbA1c effect takes about 12 weeks to register because HbA1c reflects 90-day average glucose.
How long does oral semaglutide take to work?
Rybelsus produces similar HbA1c reductions to injectable Ozempic over 12 weeks, but weight loss is roughly half because plasma levels are lower at the FDA-labeled doses.
What if I have not lost weight by week 16 on the maintenance dose?
The Wegovy label suggests reassessment if weight loss is below 5% after 16 weeks at 2.4 mg. Options include continuing for another 8 to 12 weeks, switching to tirzepatide, or addressing other contributors.
Can plateaus mean the drug stopped working?
No. Plateaus of 2 to 6 weeks are normal at any point. Most break on their own once the body adjusts. Plateaus past 8 weeks at maintenance dose warrant a prescriber conversation.
How long until semaglutide reaches steady state?
About 4 to 5 weeks, based on its 7-day half-life. This is why the first weeks feel weaker than the full effect and why dose increases take a month to fully register.

The honest summary

Semaglutide is a slow drug with a steep curve. You feel the appetite effect within two weeks. You see the scale move by week 4 to 8. You hit the big numbers between month 3 and month 16. The trial data behind those numbers comes from STEP 1, which followed roughly 1900 adults for 68 weeks and reported a mean 14.9% body weight reduction on 2.4 mg [1]. Real-world results cluster around that mean, but the spread is wide. The patients who get the best results are the ones who reach the maintenance dose on schedule, train against muscle loss, and stay on the drug long enough for the long tail to play out.

References

  1. Wilding JPH et al, Once-weekly semaglutide in adults with overweight or obesity, NEJM 2021 (STEP 1)
  2. FDA Wegovy (semaglutide) prescribing information
  3. FDA Ozempic (semaglutide) prescribing information
  4. Sorli C et al, Efficacy and safety of once-weekly semaglutide in T2D (SUSTAIN 1), Lancet Diabetes Endocrinol 2017